JP2008504881A - 非侵襲性グルコース測定 - Google Patents
非侵襲性グルコース測定 Download PDFInfo
- Publication number
- JP2008504881A JP2008504881A JP2007519286A JP2007519286A JP2008504881A JP 2008504881 A JP2008504881 A JP 2008504881A JP 2007519286 A JP2007519286 A JP 2007519286A JP 2007519286 A JP2007519286 A JP 2007519286A JP 2008504881 A JP2008504881 A JP 2008504881A
- Authority
- JP
- Japan
- Prior art keywords
- patch
- glucose
- sweat
- skin
- detector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 256
- 239000008103 glucose Substances 0.000 title claims abstract description 256
- 238000005259 measurement Methods 0.000 title claims description 123
- 210000004243 sweat Anatomy 0.000 claims abstract description 155
- 239000012528 membrane Substances 0.000 claims abstract description 54
- 238000000034 method Methods 0.000 claims abstract description 41
- 239000007933 dermal patch Substances 0.000 claims abstract description 32
- 239000000463 material Substances 0.000 claims abstract description 21
- 238000009792 diffusion process Methods 0.000 claims abstract description 17
- 230000001070 adhesive effect Effects 0.000 claims abstract description 15
- 230000004888 barrier function Effects 0.000 claims abstract description 15
- 239000000853 adhesive Substances 0.000 claims abstract description 14
- 239000004744 fabric Substances 0.000 claims abstract description 10
- 239000002904 solvent Substances 0.000 claims abstract description 8
- 238000011109 contamination Methods 0.000 claims abstract description 5
- 239000010410 layer Substances 0.000 claims description 81
- 239000000126 substance Substances 0.000 claims description 22
- 210000000106 sweat gland Anatomy 0.000 claims description 20
- 229920000642 polymer Polymers 0.000 claims description 18
- 230000007246 mechanism Effects 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 15
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 claims description 10
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 claims description 10
- 229960001416 pilocarpine Drugs 0.000 claims description 10
- 239000012491 analyte Substances 0.000 claims description 9
- 230000005540 biological transmission Effects 0.000 claims description 6
- 239000004020 conductor Substances 0.000 claims description 5
- 230000005284 excitation Effects 0.000 claims description 5
- 239000011148 porous material Substances 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000003961 penetration enhancing agent Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 230000001939 inductive effect Effects 0.000 claims description 3
- 239000002356 single layer Substances 0.000 claims description 3
- 230000004044 response Effects 0.000 abstract description 15
- 210000003491 skin Anatomy 0.000 description 114
- 239000008280 blood Substances 0.000 description 53
- 210000004369 blood Anatomy 0.000 description 53
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 34
- 206010012601 diabetes mellitus Diseases 0.000 description 21
- 102000004877 Insulin Human genes 0.000 description 18
- 229940125396 insulin Drugs 0.000 description 18
- 108090001061 Insulin Proteins 0.000 description 17
- 230000001965 increasing effect Effects 0.000 description 17
- 230000035900 sweating Effects 0.000 description 17
- 230000003287 optical effect Effects 0.000 description 16
- 210000000434 stratum corneum Anatomy 0.000 description 14
- 238000001514 detection method Methods 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 239000012790 adhesive layer Substances 0.000 description 11
- 239000003550 marker Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 230000004907 flux Effects 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 210000003722 extracellular fluid Anatomy 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000000356 contaminant Substances 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 210000000245 forearm Anatomy 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 108090001090 Lectins Proteins 0.000 description 5
- 102000004856 Lectins Human genes 0.000 description 5
- 206010040844 Skin exfoliation Diseases 0.000 description 5
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 5
- 230000035618 desquamation Effects 0.000 description 5
- 239000002523 lectin Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- -1 alkyl carboxylic acid esters Chemical class 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000002596 correlated effect Effects 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 239000010408 film Substances 0.000 description 4
- 235000019420 glucose oxidase Nutrition 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 239000004366 Glucose oxidase Substances 0.000 description 3
- 108010015776 Glucose oxidase Proteins 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 230000029142 excretion Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229940116332 glucose oxidase Drugs 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 2
- NZJXADCEESMBPW-UHFFFAOYSA-N 1-methylsulfinyldecane Chemical compound CCCCCCCCCCS(C)=O NZJXADCEESMBPW-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000009102 absorption Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003990 capacitor Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 230000002996 emotional effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- WITKSCOBOCOGSC-UHFFFAOYSA-N 2-dodecanoyloxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCCCC WITKSCOBOCOGSC-UHFFFAOYSA-N 0.000 description 1
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 description 1
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- DJHGAFSJWGLOIV-UHFFFAOYSA-K Arsenate3- Chemical compound [O-][As]([O-])([O-])=O DJHGAFSJWGLOIV-UHFFFAOYSA-K 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 108010062580 Concanavalin A Proteins 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 241000086550 Dinosauria Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 241000556720 Manga Species 0.000 description 1
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 description 1
- 229920000557 Nafion® Polymers 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 235000010749 Vicia faba Nutrition 0.000 description 1
- 244000105017 Vicia sativa Species 0.000 description 1
- 239000002998 adhesive polymer Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- DYBXVITUBPGBBW-UHFFFAOYSA-N anthracen-1-ylboronic acid Chemical compound C1=CC=C2C=C3C(B(O)O)=CC=CC3=CC2=C1 DYBXVITUBPGBBW-UHFFFAOYSA-N 0.000 description 1
- 229940000489 arsenate Drugs 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 125000005621 boronate group Chemical group 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- VSSSHNJONFTXHS-UHFFFAOYSA-N coumarin 153 Chemical compound C12=C3CCCN2CCCC1=CC1=C3OC(=O)C=C1C(F)(F)F VSSSHNJONFTXHS-UHFFFAOYSA-N 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000021045 dietary change Nutrition 0.000 description 1
- LJSQFQKUNVCTIA-UHFFFAOYSA-N diethyl sulfide Chemical compound CCSCC LJSQFQKUNVCTIA-UHFFFAOYSA-N 0.000 description 1
- 229960001673 diethyltoluamide Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 208000028208 end stage renal disease Diseases 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 238000004401 flow injection analysis Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 229920001109 fluorescent polymer Polymers 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- YBMRDBCBODYGJE-UHFFFAOYSA-N germanium oxide Inorganic materials O=[Ge]=O YBMRDBCBODYGJE-UHFFFAOYSA-N 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 230000006377 glucose transport Effects 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 1
- 238000011542 limb amputation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- XJCPMUIIBDVFDM-UHFFFAOYSA-M nile blue A Chemical compound [Cl-].C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4[O+]=C3C=C(N)C2=C1 XJCPMUIIBDVFDM-UHFFFAOYSA-M 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- PVADDRMAFCOOPC-UHFFFAOYSA-N oxogermanium Chemical compound [Ge]=O PVADDRMAFCOOPC-UHFFFAOYSA-N 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 229940026235 propylene glycol monolaurate Drugs 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000000276 sedentary effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940100640 transdermal system Drugs 0.000 description 1
- 239000006163 transport media Substances 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
- A61B5/14517—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for sweat
- A61B5/14521—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for sweat using means for promoting sweat production, e.g. heating the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0295—Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y35/00—Methods or apparatus for measurement or analysis of nanostructures
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Optics & Photonics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58541404P | 2004-07-01 | 2004-07-01 | |
| PCT/US2005/022139 WO2006007472A2 (en) | 2004-07-01 | 2005-06-22 | Non-invasive glucose measurement |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009219800A Division JP2010017572A (ja) | 2004-07-01 | 2009-09-24 | 非侵襲性グルコース測定 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008504881A true JP2008504881A (ja) | 2008-02-21 |
| JP2008504881A5 JP2008504881A5 (https=) | 2009-11-12 |
Family
ID=34981671
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007519286A Withdrawn JP2008504881A (ja) | 2004-07-01 | 2005-06-22 | 非侵襲性グルコース測定 |
| JP2009219800A Withdrawn JP2010017572A (ja) | 2004-07-01 | 2009-09-24 | 非侵襲性グルコース測定 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009219800A Withdrawn JP2010017572A (ja) | 2004-07-01 | 2009-09-24 | 非侵襲性グルコース測定 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7725149B2 (https=) |
| EP (1) | EP1776035A2 (https=) |
| JP (2) | JP2008504881A (https=) |
| KR (1) | KR20070043768A (https=) |
| CN (2) | CN101623199A (https=) |
| AU (1) | AU2005262444A1 (https=) |
| CA (1) | CA2572313A1 (https=) |
| IL (1) | IL180034A0 (https=) |
| MX (1) | MXPA06014896A (https=) |
| WO (1) | WO2006007472A2 (https=) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010519938A (ja) * | 2007-03-07 | 2010-06-10 | エコー セラピューティクス, インコーポレイテッド | 経皮的被検体モニタリングシステムおよび被検体の検出方法 |
| JP2010172588A (ja) * | 2009-01-30 | 2010-08-12 | Omron Healthcare Co Ltd | 血中成分濃度変化測定装置 |
| JP2011050733A (ja) * | 2009-08-04 | 2011-03-17 | Sysmex Corp | 組織液抽出用デバイス、その製造方法、及び該デバイスを用いた組織液の分析方法 |
| JP2017526908A (ja) * | 2014-07-14 | 2017-09-14 | ユニヴァーシテト チューリッヒ | 動物もしくは人、特に未熟児の血液または組織中の検体の濃度を自己較正の方法で測定するためのデバイス |
| KR102334848B1 (ko) * | 2020-06-12 | 2021-12-06 | 국민대학교산학협력단 | 바이오 센싱 모듈, 이의 동작 방법, 및 이를 이용하는 바이오 센싱 시스템 |
Families Citing this family (247)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8734339B2 (en) | 1996-12-16 | 2014-05-27 | Ip Holdings, Inc. | Electronic skin patch for real time monitoring of cardiac activity and personal health management |
| US6036924A (en) * | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
| US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
| US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
| US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8715177B2 (en) | 2000-10-06 | 2014-05-06 | Ip Holdings, Inc. | Intelligent drug delivery appliance |
| US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
| DE10057832C1 (de) * | 2000-11-21 | 2002-02-21 | Hartmann Paul Ag | Blutanalysegerät |
| US6560471B1 (en) * | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
| EP1397068A2 (en) | 2001-04-02 | 2004-03-17 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
| US6748250B1 (en) * | 2001-04-27 | 2004-06-08 | Medoptix, Inc. | Method and system of monitoring a patient |
| US20090137888A9 (en) * | 2001-04-27 | 2009-05-28 | Berman Herbert L | System for monitoring of patients |
| US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
| DE60234598D1 (de) | 2001-06-12 | 2010-01-14 | Pelikan Technologies Inc | Selbstoptimierende lanzettenvorrichtung mit adaptationsmittel für zeitliche schwankungen von hauteigenschaften |
| AU2002315180A1 (en) | 2001-06-12 | 2002-12-23 | Pelikan Technologies, Inc. | Electric lancet actuator |
| AU2002320094A1 (en) | 2001-06-12 | 2002-12-23 | Pelikan Technologies, Inc. | Integrated blood sampling analysis system with multi-use sampling module |
| US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
| US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| EP1404235A4 (en) * | 2001-06-12 | 2008-08-20 | Pelikan Technologies Inc | METHOD AND DEVICE FOR A LANZETTING DEVICE INTEGRATED ON A BLOOD CARTRIDGE CARTRIDGE |
| US20070100255A1 (en) * | 2002-04-19 | 2007-05-03 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| WO2002100252A2 (en) * | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
| US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
| US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| DE60239132D1 (de) * | 2001-06-12 | 2011-03-24 | Pelikan Technologies Inc | Gerät zur erhöhung der erfolgsrate im hinblick auf die durch einen fingerstich erhaltene blutausbeute |
| US7344894B2 (en) | 2001-10-16 | 2008-03-18 | Agilent Technologies, Inc. | Thermal regulation of fluidic samples within a diagnostic cartridge |
| US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7232451B2 (en) * | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7901362B2 (en) * | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7582099B2 (en) | 2002-04-19 | 2009-09-01 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
| US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7547287B2 (en) * | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US7485128B2 (en) * | 2002-04-19 | 2009-02-03 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7674232B2 (en) * | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7198606B2 (en) | 2002-04-19 | 2007-04-03 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with analyte sensing |
| US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7371247B2 (en) * | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
| US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
| US7410468B2 (en) * | 2002-04-19 | 2008-08-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
| US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
| US7374544B2 (en) | 2002-04-19 | 2008-05-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7481776B2 (en) * | 2002-04-19 | 2009-01-27 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7909778B2 (en) * | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7976476B2 (en) * | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
| US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
| US7491178B2 (en) * | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7563232B2 (en) * | 2002-04-19 | 2009-07-21 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7141058B2 (en) * | 2002-04-19 | 2006-11-28 | Pelikan Technologies, Inc. | Method and apparatus for a body fluid sampling device using illumination |
| US7524293B2 (en) * | 2002-04-19 | 2009-04-28 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
| US7727181B2 (en) * | 2002-10-09 | 2010-06-01 | Abbott Diabetes Care Inc. | Fluid delivery device with autocalibration |
| US7993108B2 (en) * | 2002-10-09 | 2011-08-09 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
| AU2003279237A1 (en) * | 2002-10-09 | 2004-05-04 | Therasense, Inc. | Fluid delivery device, system and method |
| US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
| US7811231B2 (en) | 2002-12-31 | 2010-10-12 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
| WO2004060174A2 (en) * | 2002-12-31 | 2004-07-22 | Pelikan Technologies Inc. | Method and apparatus for loading penetrating members |
| US7679407B2 (en) * | 2003-04-28 | 2010-03-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing peak detection circuitry for data communication systems |
| WO2004107964A2 (en) | 2003-06-06 | 2004-12-16 | Pelikan Technologies, Inc. | Blood harvesting device with electronic control |
| US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
| WO2005006939A2 (en) * | 2003-06-11 | 2005-01-27 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
| US7604592B2 (en) | 2003-06-13 | 2009-10-20 | Pelikan Technologies, Inc. | Method and apparatus for a point of care device |
| US8282576B2 (en) * | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
| EP1680014A4 (en) * | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | METHOD AND DEVICE FOR A VARIABLE USER INTERFACE |
| EP3175780A1 (en) | 2003-12-18 | 2017-06-07 | Metronom Health, Inc. | Implantable biosensor and methods of use thereof |
| US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
| EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
| WO2005089103A2 (en) | 2004-02-17 | 2005-09-29 | Therasense, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
| WO2006011062A2 (en) | 2004-05-20 | 2006-02-02 | Albatros Technologies Gmbh & Co. Kg | Printable hydrogel for biosensors |
| WO2005120365A1 (en) | 2004-06-03 | 2005-12-22 | Pelikan Technologies, Inc. | Method and apparatus for a fluid sampling device |
| US20070027383A1 (en) * | 2004-07-01 | 2007-02-01 | Peyser Thomas A | Patches, systems, and methods for non-invasive glucose measurement |
| AU2005262444A1 (en) | 2004-07-01 | 2006-01-19 | Vivomedical, Inc. | Non-invasive glucose measurement |
| US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
| US20060166629A1 (en) * | 2005-01-24 | 2006-07-27 | Therasense, Inc. | Method and apparatus for providing EMC Class-B compliant RF transmitter for data monitoring an detection systems |
| JP2008535548A (ja) | 2005-03-21 | 2008-09-04 | アボット ダイアビーティーズ ケア インコーポレイテッド | 統合医薬注入/検体モニタリングシステムを提供するための方法及びシステム |
| US8388523B2 (en) * | 2005-04-01 | 2013-03-05 | Welch Allyn, Inc. | Medical diagnostic instrument having portable illuminator |
| CA2603285C (en) * | 2005-04-01 | 2015-09-01 | Welch Allyn, Inc. | Vaginal speculum |
| US8112240B2 (en) * | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
| US7768408B2 (en) | 2005-05-17 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
| US7620437B2 (en) * | 2005-06-03 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
| US20060281187A1 (en) | 2005-06-13 | 2006-12-14 | Rosedale Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
| US7756561B2 (en) | 2005-09-30 | 2010-07-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
| US8801631B2 (en) | 2005-09-30 | 2014-08-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
| EP1928316B1 (en) | 2005-09-30 | 2014-02-26 | Intuity Medical, Inc. | Multi-site body fluid sampling and analysis cartridge |
| US20090196580A1 (en) * | 2005-10-06 | 2009-08-06 | Freeman Dominique M | Method and apparatus for an analyte detecting device |
| US7583190B2 (en) | 2005-10-31 | 2009-09-01 | Abbott Diabetes Care Inc. | Method and apparatus for providing data communication in data monitoring and management systems |
| US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
| US8344966B2 (en) | 2006-01-31 | 2013-01-01 | Abbott Diabetes Care Inc. | Method and system for providing a fault tolerant display unit in an electronic device |
| US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
| US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
| US8142352B2 (en) * | 2006-04-03 | 2012-03-27 | Welch Allyn, Inc. | Vaginal speculum assembly having portable illuminator |
| US8679630B2 (en) * | 2006-05-17 | 2014-03-25 | Purdue Research Foundation | Vertical carbon nanotube device in nanoporous templates |
| US20090054749A1 (en) * | 2006-05-31 | 2009-02-26 | Abbott Diabetes Care, Inc. | Method and System for Providing Data Transmission in a Data Management System |
| US7920907B2 (en) | 2006-06-07 | 2011-04-05 | Abbott Diabetes Care Inc. | Analyte monitoring system and method |
| US20080119710A1 (en) * | 2006-10-31 | 2008-05-22 | Abbott Diabetes Care, Inc. | Medical devices and methods of using the same |
| US8579853B2 (en) | 2006-10-31 | 2013-11-12 | Abbott Diabetes Care Inc. | Infusion devices and methods |
| US20080214919A1 (en) * | 2006-12-26 | 2008-09-04 | Lifescan, Inc. | System and method for implementation of glycemic control protocols |
| US9487877B2 (en) * | 2007-02-01 | 2016-11-08 | Purdue Research Foundation | Contact metallization of carbon nanotubes |
| US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
| US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
| US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
| EP2170160A4 (en) * | 2007-05-07 | 2013-01-23 | Cybiocare Inc | NON-INVASIVE PRESSURE DIRECTION |
| US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
| US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
| US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
| US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
| US20080306362A1 (en) * | 2007-06-05 | 2008-12-11 | Owen Davis | Device and system for monitoring contents of perspiration |
| US8083677B2 (en) * | 2007-09-24 | 2011-12-27 | Baxter International Inc. | Access disconnect detection using glucose |
| JP5186887B2 (ja) * | 2007-11-09 | 2013-04-24 | オムロンヘルスケア株式会社 | 血中成分濃度測定装置および血中成分濃度測定方法 |
| WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
| WO2009145920A1 (en) | 2008-05-30 | 2009-12-03 | Intuity Medical, Inc. | Body fluid sampling device -- sampling site interface |
| US20100069726A1 (en) * | 2008-06-04 | 2010-03-18 | Seventh Sense Biosystems, Inc. | Compositions and methods for rapid one-step diagnosis |
| JP5642066B2 (ja) | 2008-06-06 | 2014-12-17 | インテュイティ メディカル インコーポレイテッド | 体液の試料内に含まれている検体の存在または濃度を決定する検定を行う方法および装置 |
| EP2299904B1 (en) | 2008-06-06 | 2019-09-11 | Intuity Medical, Inc. | Medical measurement method |
| WO2010013808A1 (ja) * | 2008-07-31 | 2010-02-04 | シスメックス株式会社 | 生体内成分測定方法、生体内成分測定のためのデータ処理方法、生体内成分測定装置および収集部材 |
| WO2010030609A1 (en) * | 2008-09-09 | 2010-03-18 | Vivomedical, Inc. | Sweat collection devices for glucose measurement |
| WO2010045247A1 (en) * | 2008-10-14 | 2010-04-22 | Vivomedical, Inc. | Sweat glucose sensors and collection devices for glucose measurement |
| CA2740421C (en) * | 2008-10-15 | 2018-08-28 | The University Of Memphis Research Foundation | Method and device for detection of bioavailable drug concentration in a fluid sample |
| US11375929B2 (en) | 2008-10-15 | 2022-07-05 | The University Of Tennessee Research Foundation | Method and device for detection of bioavailable drug concentration in a fluid sample |
| JP2010167130A (ja) * | 2009-01-23 | 2010-08-05 | Omron Healthcare Co Ltd | 体液収集装置および体液分析装置 |
| US8715981B2 (en) * | 2009-01-27 | 2014-05-06 | Purdue Research Foundation | Electrochemical biosensor |
| US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
| US20100198196A1 (en) * | 2009-01-30 | 2010-08-05 | Abbott Diabetes Care, Inc. | Therapy Delivery Device Programming Tool |
| US8560082B2 (en) | 2009-01-30 | 2013-10-15 | Abbott Diabetes Care Inc. | Computerized determination of insulin pump therapy parameters using real time and retrospective data processing |
| US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
| WO2012018486A2 (en) | 2010-07-26 | 2012-02-09 | Seventh Sense Biosystems, Inc. | Rapid delivery and/or receiving of fluids |
| CN102405018B (zh) | 2009-03-02 | 2014-11-19 | 第七感生物系统有限公司 | 与血液取样相关联的技术和装置 |
| US20110105872A1 (en) * | 2009-10-30 | 2011-05-05 | Seventh Sense Biosystems, Inc. | Systems and methods for application to skin and control of actuation, delivery, and/or perception thereof |
| US9041541B2 (en) * | 2010-01-28 | 2015-05-26 | Seventh Sense Biosystems, Inc. | Monitoring or feedback systems and methods |
| US9295417B2 (en) | 2011-04-29 | 2016-03-29 | Seventh Sense Biosystems, Inc. | Systems and methods for collecting fluid from a subject |
| US8872154B2 (en) * | 2009-04-06 | 2014-10-28 | Purdue Research Foundation | Field effect transistor fabrication from carbon nanotubes |
| US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
| US8467972B2 (en) * | 2009-04-28 | 2013-06-18 | Abbott Diabetes Care Inc. | Closed loop blood glucose control algorithm analysis |
| WO2010138856A1 (en) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
| DK3936032T3 (da) | 2009-07-23 | 2024-07-29 | Abbott Diabetes Care Inc | Realtidshåndtering af data relateret til fysiologisk styring af glukoseniveauer |
| US8993331B2 (en) | 2009-08-31 | 2015-03-31 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
| EP2473098A4 (en) | 2009-08-31 | 2014-04-09 | Abbott Diabetes Care Inc | ANALYTICAL SIGNAL PROCESSING APPARATUS AND METHOD |
| US9320461B2 (en) * | 2009-09-29 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
| JP2011232320A (ja) * | 2009-10-01 | 2011-11-17 | Sony Corp | 生体内物質検出用プローブ、および該生体内物質検出用プローブを用いた生体内物質検出装置 |
| WO2011065972A2 (en) * | 2009-11-24 | 2011-06-03 | Seventh Sense Biosystems, Inc. | Patient-enacted sampling technique |
| EP2506768B1 (en) | 2009-11-30 | 2016-07-06 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
| WO2011081596A1 (en) * | 2009-12-30 | 2011-07-07 | Cma Microdialysis Ab | Sensor arrangement for continuously measuring analytes in a biological fluid |
| CN102119860B (zh) * | 2010-01-12 | 2013-07-17 | 长庚医学科技股份有限公司 | 非侵入式血糖量测系统和测量方法 |
| JP5826766B2 (ja) * | 2010-01-13 | 2015-12-02 | セブンス センス バイオシステムズ,インコーポレーテッド | 試料採取デバイスインタフェース |
| CN102811754B (zh) * | 2010-01-13 | 2017-05-17 | 第七感生物系统有限公司 | 流体的快速输送和/或抽出 |
| JP5735773B2 (ja) * | 2010-03-29 | 2015-06-17 | シスメックス株式会社 | 生体成分分析方法及び生体成分分析装置 |
| US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| CN103108587B (zh) * | 2010-05-17 | 2016-09-21 | 申提留斯控股有限公司 | 检测装置和相关使用方法 |
| GB201008448D0 (en) * | 2010-05-20 | 2010-07-07 | Univ Strathclyde | Transdermal device |
| WO2011163347A2 (en) | 2010-06-23 | 2011-12-29 | Seventh Sense Biosystems, Inc. | Sampling devices and methods involving relatively little pain |
| WO2012009613A1 (en) | 2010-07-16 | 2012-01-19 | Seventh Sense Biosystems, Inc. | Low-pressure environment for fluid transfer devices |
| WO2012021801A2 (en) | 2010-08-13 | 2012-02-16 | Seventh Sense Biosystems, Inc. | Systems and techniques for monitoring subjects |
| EP2992827B1 (en) | 2010-11-09 | 2017-04-19 | Seventh Sense Biosystems, Inc. | Systems and interfaces for blood sampling |
| JP5801590B2 (ja) * | 2011-04-11 | 2015-10-28 | シスメックス株式会社 | 生体成分測定方法 |
| US20130158468A1 (en) | 2011-12-19 | 2013-06-20 | Seventh Sense Biosystems, Inc. | Delivering and/or receiving material with respect to a subject surface |
| CN103874460B (zh) | 2011-04-29 | 2016-06-22 | 第七感生物系统有限公司 | 一种用于从受验者的皮肤接收血液或其它物质的装置 |
| KR20140034200A (ko) | 2011-04-29 | 2014-03-19 | 세븐쓰 센스 바이오시스템즈, 인크. | 혈액 스폿들 또는 다른 신체 유체들을 수집 및/또는 조작하기 위한 시스템들 및 방법들 |
| CA2843945C (en) | 2011-08-03 | 2022-06-21 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
| US20130060106A1 (en) | 2011-09-06 | 2013-03-07 | Medtronic Minimed, Inc. | Optical sensing systems and methods |
| WO2013064313A1 (en) | 2011-10-31 | 2013-05-10 | Sentec Ag | A device for application of a sensor to a measurement site, a sensor head, a kit of an application device and sensor and use of an application device for optical measurements of physiological parameters |
| EP3677182B1 (en) | 2011-11-07 | 2022-05-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
| RU2653633C2 (ru) * | 2012-03-01 | 2018-05-11 | Конинклейке Филипс Н.В. | Датчик определения концентрации газа |
| EP2834007B1 (en) | 2012-04-04 | 2019-06-26 | University of Cincinnati | Device and method for sweat collection |
| US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
| DK2941195T3 (en) | 2013-01-02 | 2017-03-06 | Fibrotx Oü | Device for measuring analytes in the skin |
| CN105408493A (zh) * | 2013-07-31 | 2016-03-16 | 圣铁克私人有限公司 | 用于测量生物流体中的分析物的系统、装置、媒介及方法 |
| WO2015051288A1 (en) * | 2013-10-03 | 2015-04-09 | Leszinske Alan J | Apparatus and method for automated blood analyte monitoring |
| WO2015057743A1 (en) * | 2013-10-14 | 2015-04-23 | Theranos, Inc. | Methods and systems for obtaining clinical samples |
| CA2927213A1 (en) | 2013-10-18 | 2015-04-23 | University Of Cincinnati | Sweat sensing with chronological assurance |
| US10888244B2 (en) | 2013-10-18 | 2021-01-12 | University Of Cincinnati | Sweat sensing with chronological assurance |
| EP3165154A3 (en) | 2013-10-18 | 2017-07-26 | University of Cincinnati | Devices for integrated, repeated, prolonged, and/or reliable sweat stimulation and biosensing |
| US9459089B2 (en) * | 2014-04-09 | 2016-10-04 | Qualcomm Incorporated | Method, devices and systems for detecting an attachment of an electronic patch |
| WO2015184097A2 (en) | 2014-05-28 | 2015-12-03 | University Of Cincinnati | Devices with reduced sweat volumes between sensors and sweat glands |
| EP3148420A4 (en) | 2014-05-28 | 2018-09-19 | University of Cincinnati | Sweat monitoring and control of drug delivery |
| US10932761B2 (en) | 2014-05-28 | 2021-03-02 | University Of Cincinnati | Advanced sweat sensor adhesion, sealing, and fluidic strategies |
| US9532706B2 (en) | 2014-08-07 | 2017-01-03 | Welch Allyn, Inc. | Vaginal speculum with illuminator |
| EP3197343A4 (en) * | 2014-09-22 | 2018-04-18 | University of Cincinnati | Sweat sensing with analytical assurance |
| CN104280444B (zh) * | 2014-10-15 | 2019-12-17 | 南京皓运投资管理有限公司 | 汗液收集及分析系统及其制作方法 |
| KR102335739B1 (ko) * | 2014-12-19 | 2021-12-06 | 삼성전자주식회사 | 비 침습적 혈당 측정 방법 및 이를 위한 장치 |
| KR20160089718A (ko) | 2015-01-20 | 2016-07-28 | 삼성전자주식회사 | 센서 모듈 및 그를 구비하는 착용형 체성분 분석 장치 |
| WO2016117520A1 (ja) * | 2015-01-21 | 2016-07-28 | 国立研究開発法人日本原子力研究開発機構 | 血中物質濃度測定装置及び血中物質濃度測定方法 |
| CN104545817B (zh) * | 2015-01-29 | 2017-09-29 | 长沙一卫医疗科技有限公司 | 一种非介入检测汗腺汗液离子状况的传感器 |
| US10485460B2 (en) | 2015-02-13 | 2019-11-26 | University Of Cincinnati | Devices for integrated indirect sweat stimulation and sensing |
| US20180042585A1 (en) * | 2015-02-20 | 2018-02-15 | University Of Cincinnati | Sweat sensing devices with prioritized sweat data from a subset of sensors |
| KR101789703B1 (ko) * | 2015-06-12 | 2017-10-25 | 서울대학교산학협력단 | 바이오 센서 및 그 형성 방법 |
| GB201510909D0 (en) * | 2015-06-22 | 2015-08-05 | Surescreen Diagnostics Ltd | Detection apparatus |
| US20180292325A1 (en) * | 2015-06-23 | 2018-10-11 | Case Western Reserve University | Systems and methods for optochemical imaging of a chemically active surface |
| US10695000B2 (en) | 2015-09-02 | 2020-06-30 | Metronom Health, Inc. | Systems and methods for continuous health monitoring using an opto-enzymatic analyte sensor |
| US20170065231A1 (en) * | 2015-09-04 | 2017-03-09 | Goldensunda Technology Co., Ltd. | Noninvasive blood sugar measurement device |
| ITUB20154036A1 (it) * | 2015-09-30 | 2017-03-30 | St Microelectronics Srl | Biosensore per il rilevamento di analiti nel sudore, e metodo di fabbricazione del biosensore |
| CN108430308A (zh) | 2015-10-30 | 2018-08-21 | 辛辛那提大学 | 具有电磁屏蔽传感器、互连和电子器件的汗液感测设备 |
| WO2017087912A2 (en) * | 2015-11-20 | 2017-05-26 | Duke University | Ratiometric biosensors and non-geometrically modulated fret |
| GB2535614B (en) | 2015-12-22 | 2017-06-14 | Tfm Invent Ltd | A skin patch |
| US10993657B1 (en) * | 2015-12-30 | 2021-05-04 | Halo Wearables, Llc | Wearable hydration monitor sensors |
| CN106983516A (zh) * | 2016-01-20 | 2017-07-28 | 金上达科技股份有限公司 | 非侵入式血糖检测装置 |
| US10746663B2 (en) * | 2016-02-26 | 2020-08-18 | DermaTec LLC | Methods and apparatuses relating to dermal biochemical sensors |
| PT3216395T (pt) * | 2016-03-11 | 2021-10-15 | Hoffmann La Roche | Adesivo de medição de analito |
| US10471249B2 (en) | 2016-06-08 | 2019-11-12 | University Of Cincinnati | Enhanced analyte access through epithelial tissue |
| US11253190B2 (en) | 2016-07-01 | 2022-02-22 | University Of Cincinnati | Devices with reduced microfluidic volume between sensors and sweat glands |
| WO2018035443A1 (en) | 2016-08-19 | 2018-02-22 | University Of Cincinnati | Prolonged sweat stimulation |
| WO2018039652A1 (en) * | 2016-08-26 | 2018-03-01 | Cardiac Pacemakers, Inc. | Systems and methods for determining an abnormal glycemic event using surrogates for glucose |
| AU2017340405B2 (en) * | 2016-10-04 | 2023-06-29 | Ch2M Hill, Inc. | Passive device for vapor intrusion sampling |
| GB2559627A (en) * | 2017-02-14 | 2018-08-15 | Ndm Tech Ltd | Device |
| US10506926B2 (en) | 2017-02-18 | 2019-12-17 | Arc Devices Limited | Multi-vital sign detector in an electronic medical records system |
| US10492684B2 (en) | 2017-02-21 | 2019-12-03 | Arc Devices Limited | Multi-vital-sign smartphone system in an electronic medical records system |
| WO2018165180A1 (en) | 2017-03-06 | 2018-09-13 | Medtronic Minimed, Inc. | Colorometric sensor for the non-invasive screening of glucose in sweat in pre and type 2 diabetes |
| US20180249935A1 (en) * | 2017-03-06 | 2018-09-06 | Medtronic Minimed, Inc. | Colorometric sensor for the non-invasive screening of glucose in sweat in pre and type 2 diabetes |
| KR101947586B1 (ko) * | 2017-05-31 | 2019-04-29 | 광운대학교 산학협력단 | 혈당 측정기 및 이를 이용한 혈당 측정 시스템 |
| US10602987B2 (en) | 2017-08-10 | 2020-03-31 | Arc Devices Limited | Multi-vital-sign smartphone system in an electronic medical records system |
| WO2019051107A1 (en) * | 2017-09-07 | 2019-03-14 | The Regents Of The University Of California | PORTABLE MULTI-PUSH SENSOR EXTRACTION AND DETECTION DEVICE FOR STANDARDIZED AND SEQUENTIAL SWEAT ANALYSIS IN TIME |
| US11857313B2 (en) | 2017-09-11 | 2024-01-02 | University Of Cincinnati | Sweat biosensing companion devices and subsystems |
| US11490862B2 (en) * | 2017-11-13 | 2022-11-08 | Senseonics, Incorporated | Analyte monitoring system and method for determining system usage |
| US20210076991A1 (en) * | 2018-01-16 | 2021-03-18 | The Regents Of The University Of California | In-situ sweat rate monitoring for normalization of sweat analyte concentrations |
| CN108451550B (zh) * | 2018-01-29 | 2021-03-19 | 肖向梅 | 一种化验科医用手部体液采验器 |
| CN108742647A (zh) * | 2018-04-30 | 2018-11-06 | 中山市京春电子科技有限公司 | 一种便携式血糖检测设备 |
| US10485431B1 (en) | 2018-05-21 | 2019-11-26 | ARC Devices Ltd. | Glucose multi-vital-sign system in an electronic medical records system |
| US20210338117A1 (en) * | 2018-09-05 | 2021-11-04 | Kwangwoon University Industry-Academic Collaboration Foundation | Blood glucose measurement device and blood glucose measurement system using same |
| KR102655742B1 (ko) * | 2018-09-11 | 2024-04-05 | 삼성전자주식회사 | 분석 물질의 혈중 농도 측정 장치 및 방법 |
| CN113194814A (zh) * | 2018-11-13 | 2021-07-30 | 辛辛那提大学 | 所采集的间质液样本的质量保证 |
| CN109646018A (zh) * | 2019-01-17 | 2019-04-19 | 浙江大学 | 一种用于汗液葡萄糖检测的无线无源柔性传感装置及方法 |
| EP3756544A1 (en) * | 2019-06-26 | 2020-12-30 | Koninklijke Philips N.V. | System and method for correcting a sweat analyte measurement |
| US20210106260A1 (en) * | 2019-10-11 | 2021-04-15 | The Regents Of The University Of California | Mediator-free biochemical sensing device and method for noninvasively and electrochemically sensing in vivo biochemicals |
| WO2021247300A1 (en) | 2020-06-01 | 2021-12-09 | Arc Devices Limited | Apparatus and methods for measuring blood pressure and other vital signs via a finger |
| US20220061705A1 (en) * | 2020-08-05 | 2022-03-03 | The Regents Of The University Of California | Programmable epidermal microfluidic valving system for wearable biofluid management and contextual biomarker analysis |
| CN111982869B (zh) * | 2020-08-06 | 2023-09-19 | 中国科学院合肥物质科学研究院 | 一种用于定量荧光测量的校准方法及校准配件 |
| KR102758471B1 (ko) * | 2021-11-30 | 2025-01-22 | 계명대학교 산학협력단 | 글루코스 및 락테이트 동시측정 바이오 센서 |
| CN114652306A (zh) * | 2022-03-17 | 2022-06-24 | 电子科技大学 | 基于MOFs的指尖接触式无创汗液葡萄糖传感器及方法 |
| JP2025521184A (ja) | 2022-06-03 | 2025-07-08 | アーク デヴァイシズ リミテッド | 手指を介して血圧及び他のバイタルサインを測定する装置及び方法 |
| CN115655957A (zh) * | 2022-09-27 | 2023-01-31 | 安阳工学院 | 一种以汗液测血糖的血糖仪 |
| CN116195997A (zh) * | 2022-11-22 | 2023-06-02 | 厦门大学深圳研究院 | 汗液葡萄糖浓度检测系统 |
| CN116297734A (zh) * | 2023-02-22 | 2023-06-23 | 桂林电子科技大学 | 一种基于多步电压阶跃法的汗液葡萄糖检测装置及方法 |
| CN119174607A (zh) * | 2024-08-19 | 2024-12-24 | 宁波大学 | 一种用于汗液中葡萄糖检测的可穿戴贴片及其制备方法与应用 |
Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6272321A (ja) * | 1985-09-26 | 1987-04-02 | 株式会社日立製作所 | 汗中有機物及び電解質検出用経皮センサ |
| JPS6331638A (ja) * | 1986-07-26 | 1988-02-10 | 株式会社日立製作所 | 無侵襲生化学物質計測装置 |
| JPH01163666A (ja) * | 1987-08-18 | 1989-06-27 | Dermal Syst Internatl | 皮膚透過物検出システム |
| US5036861A (en) * | 1990-01-11 | 1991-08-06 | Sembrowich Walter L | Method and apparatus for non-invasively monitoring plasma glucose levels |
| US5140985A (en) * | 1989-12-11 | 1992-08-25 | Schroeder Jon M | Noninvasive blood glucose measuring device |
| US5443080A (en) * | 1993-12-22 | 1995-08-22 | Americate Transtech, Inc. | Integrated system for biological fluid constituent analysis |
| JPH10503846A (ja) * | 1994-08-01 | 1998-04-07 | メディセンス インコーポレイテッド | 電極およびその分析における使用 |
| JPH11506624A (ja) * | 1995-06-07 | 1999-06-15 | スダー パートナーズ | 別個の吸収性材料を欠く皮膚用パッチ |
| JP2002513602A (ja) * | 1998-04-30 | 2002-05-14 | セラセンス、インク. | 分析物モニタシステムおよびその使用方法 |
| JP2002535039A (ja) * | 1999-01-22 | 2002-10-22 | スリーエム イノベイティブ プロパティズ カンパニー | 流体制御膜を備える医療物品 |
| US6479015B1 (en) * | 1998-03-03 | 2002-11-12 | Pepex Biomedical, Llc | Apparatus for monitoring a level of a chemical species in a body fluid |
| WO2003015636A1 (en) * | 2001-08-18 | 2003-02-27 | Psimedica Limited | Body fluid collection and analysis |
| WO2004001373A2 (en) * | 2002-04-22 | 2003-12-31 | Marcio Marc Abreu | Apparatus and method for measuring biologic parameters |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3551554A (en) | 1968-08-16 | 1970-12-29 | Crown Zellerbach Corp | Enhancing tissue penetration of physiologically active agents with dmso |
| US4444193A (en) * | 1982-01-11 | 1984-04-24 | Medtronic, Inc. | Fluid absorbent quantitative test device |
| US5441048A (en) | 1988-09-08 | 1995-08-15 | Sudor Partners | Method and apparatus for determination of chemical species in perspiration |
| US5465713A (en) * | 1988-09-08 | 1995-11-14 | Sudor Partners | Energy-assisted transdermal collection patch for accelerated analyte collection and method of use |
| US5306861A (en) | 1990-10-31 | 1994-04-26 | Amos Philip I | Temporary wall covering |
| US20020169394A1 (en) * | 1993-11-15 | 2002-11-14 | Eppstein Jonathan A. | Integrated tissue poration, fluid harvesting and analysis device, and method therefor |
| CZ288371B6 (en) | 1994-06-30 | 2001-06-13 | Procter & Gamble | Structure for transport of liquids and process for producing thereof |
| SE510733C2 (sv) | 1995-01-03 | 1999-06-21 | Chemel Ab | Kemisk sensor baserad på utbytbar igenkänningskomponent samt användning därav |
| US5954685A (en) * | 1996-05-24 | 1999-09-21 | Cygnus, Inc. | Electrochemical sensor with dual purpose electrode |
| WO1998022820A1 (en) | 1996-11-21 | 1998-05-28 | Lawrence Livermore National Laboratory | Detection of biological molecules using boronate-based chemical amplification and optical sensors |
| US6503198B1 (en) | 1997-09-11 | 2003-01-07 | Jack L. Aronowtiz | Noninvasive transdermal systems for detecting an analyte obtained from or underneath skin and methods |
| US6117290A (en) | 1997-09-26 | 2000-09-12 | Pepex Biomedical, Llc | System and method for measuring a bioanalyte such as lactate |
| US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| PT1077636E (pt) * | 1998-05-13 | 2004-06-30 | Cygnus Therapeutic Systems | Processamento de sinal para medicao de analitos fisiologicos |
| JP3507437B2 (ja) * | 1998-05-13 | 2004-03-15 | シグナス, インコーポレイテッド | 経皮サンプリング系のための収集アセンブリ |
| US6128519A (en) | 1998-12-16 | 2000-10-03 | Pepex Biomedical, Llc | System and method for measuring a bioanalyte such as lactate |
| US20040171980A1 (en) | 1998-12-18 | 2004-09-02 | Sontra Medical, Inc. | Method and apparatus for enhancement of transdermal transport |
| DE60028991T2 (de) | 1999-10-07 | 2007-02-08 | Pepex Biomedical, LLC, Alameda | Sensor, bestehend aus einer isolierenden Ummantelung, enthaltend darin eine Vielzahl von leitfähigen Fasern, die zumindestens teilweise von einem sensitiven Material umgeben sind und Hohlräume zwischen den Fasern enthalten |
| US6464849B1 (en) | 1999-10-07 | 2002-10-15 | Pepex Biomedical, L.L.C. | Sensor for measuring a bioanalyte such as lactate |
| US7323143B2 (en) | 2000-05-25 | 2008-01-29 | President And Fellows Of Harvard College | Microfluidic systems including three-dimensionally arrayed channel networks |
| CA2409826C (en) | 2000-06-01 | 2010-02-02 | Science Applications International Corporation | Systems and methods for monitoring health and delivering drugs transdermally |
| US6905816B2 (en) | 2000-11-27 | 2005-06-14 | Intelligent Medical Devices, Inc. | Clinically intelligent diagnostic devices and methods |
| GB0030929D0 (en) * | 2000-12-19 | 2001-01-31 | Inverness Medical Ltd | Analyte measurement |
| US20050009101A1 (en) | 2001-05-17 | 2005-01-13 | Motorola, Inc. | Microfluidic devices comprising biochannels |
| CA2464738A1 (en) * | 2001-11-09 | 2003-05-15 | Dow Global Technologies Inc. | Hand-held medical apparatus |
| US7892183B2 (en) * | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US7198606B2 (en) * | 2002-04-19 | 2007-04-03 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with analyte sensing |
| US8849379B2 (en) * | 2002-04-22 | 2014-09-30 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
| US20030215487A1 (en) * | 2002-05-17 | 2003-11-20 | Il Yang Pharm Co., Ltd. Republic Of Korea | Matrix-type device for the transdermal delivery of testosterone applied to the non-scrotal skin |
| US6998598B2 (en) * | 2002-08-02 | 2006-02-14 | Sandia National Labroatories | Modular optical detector system |
| US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
| US20040214492A1 (en) | 2003-04-22 | 2004-10-28 | Martz Joel D. | Hybrid microporous membrane |
| US7494465B2 (en) | 2004-07-13 | 2009-02-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
| WO2005084257A2 (en) | 2004-02-26 | 2005-09-15 | Vpn Solutions, Llc | Composite thin-film glucose sensor |
| US20070027383A1 (en) | 2004-07-01 | 2007-02-01 | Peyser Thomas A | Patches, systems, and methods for non-invasive glucose measurement |
| AU2005262444A1 (en) | 2004-07-01 | 2006-01-19 | Vivomedical, Inc. | Non-invasive glucose measurement |
| US8989833B2 (en) | 2004-07-13 | 2015-03-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
| US20070027381A1 (en) | 2005-07-29 | 2007-02-01 | Therasense, Inc. | Inserter and methods of use |
| US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
| US20070179373A1 (en) | 2005-12-22 | 2007-08-02 | Provex Technologies, Llc. | Integrated patch and assay device with visual detection means |
| JP2006250949A (ja) | 2006-05-15 | 2006-09-21 | Japan Science & Technology Agency | 皮膚表面に存在するグルコース測定方法 |
-
2005
- 2005-06-22 AU AU2005262444A patent/AU2005262444A1/en not_active Abandoned
- 2005-06-22 CN CN200910145623A patent/CN101623199A/zh active Pending
- 2005-06-22 JP JP2007519286A patent/JP2008504881A/ja not_active Withdrawn
- 2005-06-22 KR KR1020077000105A patent/KR20070043768A/ko not_active Withdrawn
- 2005-06-22 MX MXPA06014896A patent/MXPA06014896A/es not_active Application Discontinuation
- 2005-06-22 CN CNB2005800250985A patent/CN100512747C/zh not_active Expired - Fee Related
- 2005-06-22 WO PCT/US2005/022139 patent/WO2006007472A2/en not_active Ceased
- 2005-06-22 EP EP05762354A patent/EP1776035A2/en not_active Withdrawn
- 2005-06-22 CA CA002572313A patent/CA2572313A1/en not_active Abandoned
- 2005-06-22 US US11/159,587 patent/US7725149B2/en not_active Expired - Fee Related
-
2006
- 2006-12-13 IL IL180034A patent/IL180034A0/en unknown
-
2009
- 2009-09-24 JP JP2009219800A patent/JP2010017572A/ja not_active Withdrawn
Patent Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6272321A (ja) * | 1985-09-26 | 1987-04-02 | 株式会社日立製作所 | 汗中有機物及び電解質検出用経皮センサ |
| JPS6331638A (ja) * | 1986-07-26 | 1988-02-10 | 株式会社日立製作所 | 無侵襲生化学物質計測装置 |
| JPH01163666A (ja) * | 1987-08-18 | 1989-06-27 | Dermal Syst Internatl | 皮膚透過物検出システム |
| US5140985A (en) * | 1989-12-11 | 1992-08-25 | Schroeder Jon M | Noninvasive blood glucose measuring device |
| US5036861A (en) * | 1990-01-11 | 1991-08-06 | Sembrowich Walter L | Method and apparatus for non-invasively monitoring plasma glucose levels |
| US5443080A (en) * | 1993-12-22 | 1995-08-22 | Americate Transtech, Inc. | Integrated system for biological fluid constituent analysis |
| JPH10503846A (ja) * | 1994-08-01 | 1998-04-07 | メディセンス インコーポレイテッド | 電極およびその分析における使用 |
| JPH11506624A (ja) * | 1995-06-07 | 1999-06-15 | スダー パートナーズ | 別個の吸収性材料を欠く皮膚用パッチ |
| US6479015B1 (en) * | 1998-03-03 | 2002-11-12 | Pepex Biomedical, Llc | Apparatus for monitoring a level of a chemical species in a body fluid |
| JP2002513602A (ja) * | 1998-04-30 | 2002-05-14 | セラセンス、インク. | 分析物モニタシステムおよびその使用方法 |
| JP2002535039A (ja) * | 1999-01-22 | 2002-10-22 | スリーエム イノベイティブ プロパティズ カンパニー | 流体制御膜を備える医療物品 |
| WO2003015636A1 (en) * | 2001-08-18 | 2003-02-27 | Psimedica Limited | Body fluid collection and analysis |
| WO2004001373A2 (en) * | 2002-04-22 | 2003-12-31 | Marcio Marc Abreu | Apparatus and method for measuring biologic parameters |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010519938A (ja) * | 2007-03-07 | 2010-06-10 | エコー セラピューティクス, インコーポレイテッド | 経皮的被検体モニタリングシステムおよび被検体の検出方法 |
| JP2013230403A (ja) * | 2007-03-07 | 2013-11-14 | Echo Therapeutics Inc | 経皮的被検体モニタリングシステムおよび被検体の検出方法 |
| JP2010172588A (ja) * | 2009-01-30 | 2010-08-12 | Omron Healthcare Co Ltd | 血中成分濃度変化測定装置 |
| JP2011050733A (ja) * | 2009-08-04 | 2011-03-17 | Sysmex Corp | 組織液抽出用デバイス、その製造方法、及び該デバイスを用いた組織液の分析方法 |
| JP2017526908A (ja) * | 2014-07-14 | 2017-09-14 | ユニヴァーシテト チューリッヒ | 動物もしくは人、特に未熟児の血液または組織中の検体の濃度を自己較正の方法で測定するためのデバイス |
| KR102334848B1 (ko) * | 2020-06-12 | 2021-12-06 | 국민대학교산학협력단 | 바이오 센싱 모듈, 이의 동작 방법, 및 이를 이용하는 바이오 센싱 시스템 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20060004271A1 (en) | 2006-01-05 |
| WO2006007472A3 (en) | 2006-06-08 |
| CA2572313A1 (en) | 2006-01-19 |
| KR20070043768A (ko) | 2007-04-25 |
| MXPA06014896A (es) | 2007-08-20 |
| CN101623199A (zh) | 2010-01-13 |
| US7725149B2 (en) | 2010-05-25 |
| IL180034A0 (en) | 2007-05-15 |
| EP1776035A2 (en) | 2007-04-25 |
| CN100512747C (zh) | 2009-07-15 |
| WO2006007472A2 (en) | 2006-01-19 |
| CN101005798A (zh) | 2007-07-25 |
| WO2006007472B1 (en) | 2006-07-06 |
| AU2005262444A1 (en) | 2006-01-19 |
| JP2010017572A (ja) | 2010-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7725149B2 (en) | Devices, methods, and kits for non-invasive glucose measurement | |
| US20070179371A1 (en) | Patches, systems, and methods for non-invasive glucose measurement | |
| US9354226B2 (en) | Transdermal systems, devices, and methods to optically analyze an analyte | |
| JP4584338B2 (ja) | 分析対象物を検出する非侵襲性経皮システム | |
| US5890489A (en) | Method for non-invasive determination of glucose in body fluids | |
| US8684930B2 (en) | Method of calibrating an analyte-measurement device, and associated methods, devices and systems | |
| US7949382B2 (en) | Devices, systems, methods and tools for continuous glucose monitoring | |
| US20080234562A1 (en) | Continuous analyte monitor with multi-point self-calibration | |
| JP5253303B2 (ja) | 種々のサンプル量を受容するための検体試験片 | |
| CA2426249A1 (en) | Glucose measurement utilizing non-invasive assessment methods | |
| US20120252046A1 (en) | Transdermal systems, devices, and methods for biological analysis | |
| US20110257497A1 (en) | Flux Enhancement in Continuous Glucose Monitoring | |
| JP5221455B2 (ja) | 体液における検体を測定するための方法 | |
| JP2010008412A (ja) | 種々のサンプル量を受容するための検体試験片を製造する方法 | |
| Cunningham | Blood glucose monitoring | |
| Aroutiounian | Saliva Sensors. | |
| Jang et al. | A New Approach to Glucose Monitoring Using a Non Invasive Ocular Amperometric Electro Chemical Glucose Sensor for the Diabetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080303 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090924 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20100212 |
|
| A072 | Dismissal of procedure [no reply to invitation to correct request for examination] |
Free format text: JAPANESE INTERMEDIATE CODE: A073 Effective date: 20100706 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110124 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110627 |